Unspecified Adult Solid Tumor Clinical Trial
Official title:
Holographic Mm-wave Imaging in Radiation Oncology
This trial studies the quality of holographic mm-wave imaging in patients undergoing radiation therapy. Holographic mm-wave imaging is a common type of imaging used in airport body scanners that may be helpful in improving the efficiency and positioning of radiation oncology patients and their overall experience.
PRIMARY OBJECTIVES: I. To obtain patient images in a clinical setting and assess their quality. SECONDARY OBJECTIVES: I. To assess the registration agreement through a voxel-voxel distance-to-agreement metric. OUTLINE: Patients undergo holographic mm-wave imaging in radiotherapy treatment position after initial computed tomography (CT) simulation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01450384 -
Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT00477607 -
Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin
|
Phase 2/Phase 3 | |
| Completed |
NCT02049593 -
PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors
|
Phase 1 | |
| Terminated |
NCT00938457 -
Stereotactic Radiation Therapy in Treating Patients With Liver Metastases
|
Phase 1/Phase 2 | |
| Suspended |
NCT01843413 -
Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases
|
N/A | |
| Completed |
NCT02324621 -
Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT00390156 -
Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors
|
Phase 1 | |
| Completed |
NCT00037804 -
Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction
|
Phase 1 |